CAMP

Camp4 Therapeutics (CAMP)

About Camp4 Therapeutics (CAMP)

CAMP4 Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a class of RNA-targeting therapeutics for upregulating gene expression and restoration of healthy protein levels to treat a broad range of genetic diseases. Its lead product candidate is CMP-002. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

Details

Daily high

$4.60

Daily low

$4.15

Price at open

$4.58

52 Week High

$7.75

52 Week Low

$1.32

Market cap

233.7M

Dividend yield

0.00%

Volume

782

Avg. volume

207,670

P/E ratio

-1.98

Camp4 Therapeutics News